Literature DB >> 12751914

Labour force participation among individuals with hepatitis C in the US.

Philip Jacobs1, Ying Chu Ng, Tania Stafinski, Roger Dodd, Bryce Larke, Winnie Wong.   

Abstract

BACKGROUND: In 1996, the number of persons newly infected with hepatitis C virus (HCV) in the US was estimated to be 36 000. As a chronic disease that primarily affects younger persons, hepatitis C has the potential to influence employment considerably.
OBJECTIVE: To estimate employment effects associated with hepatitis C morbidity.
DESIGN: An economic model of labour supply, which used the outcome measure workforce participation (yes/no), was applied. STUDY PARTICIPANTS: The study samples (by gender) were comprised of persons 18-65 years of age, with and without serological evidence of HCV infection, and with normal or elevated levels of alanine aminotransferase (ALT) who participated in the National Health and Nutrition Examination Survey III from 1988-1994.
RESULTS: After controlling for the potential confounding effects of demographic, social, and economic factors, positive HCV status/normal ALT level in males was associated with a 10.7% reduction in labour force participation (when compared with negative HCV status). Positive HCV status and elevated ALT levels was associated with a 17.5% reduction in employment. The results for females were not statistically significant.
CONCLUSIONS: Nationally, the employment response for HCV-positive status and elevated ALT levels translates into an excess non-employment of 48 000 males annually.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12751914     DOI: 10.2165/00019053-200321080-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  11 in total

Review 1.  Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis.

Authors:  D V Gopal; H R Rosen
Journal:  Postgrad Med       Date:  2000-02       Impact factor: 3.840

2.  Summary of Notifiable Diseases, United States, 1998.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-12-31       Impact factor: 17.586

3.  The cost of hepatitis C and the cost-effectiveness of its prevention.

Authors:  A Shiell; M G Law
Journal:  Health Policy       Date:  2001-11       Impact factor: 2.980

4.  Estimating future hepatitis C morbidity, mortality, and costs in the United States.

Authors:  J B Wong; G M McQuillan; J G McHutchison; T Poynard
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

5.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

6.  The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Authors:  D L Thomas; J Astemborski; R M Rai; F A Anania; M Schaeffer; N Galai; K Nolt; K E Nelson; S A Strathdee; L Johnson; O Laeyendecker; J Boitnott; L E Wilson; D Vlahov
Journal:  JAMA       Date:  2000-07-26       Impact factor: 56.272

7.  Costs of hepatitis C.

Authors:  J P Leigh; C L Bowlus; B N Leistikow; M Schenker
Journal:  Arch Intern Med       Date:  2001-10-08

Review 8.  Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome.

Authors:  H J Alter; L B Seeff
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

9.  Disability and the labour market: an analysis of British males.

Authors:  M P Kidd; P J Sloane; I Ferko
Journal:  J Health Econ       Date:  2000-11       Impact factor: 3.883

10.  Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal.

Authors:  G M Dusheiko; J A Roberts
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  2 in total

1.  Intra-individual variability across neurocognitive domains in chronic hepatitis C infection: elevated dispersion is associated with serostatus and unemployment risk.

Authors:  Erin E Morgan; Steven Paul Woods; Alexandra Rooney; William Perry; Igor Grant; Scott L Letendre
Journal:  Clin Neuropsychol       Date:  2012-04-26       Impact factor: 3.535

2.  Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C.

Authors:  Maiko Sakamoto; Steven Paul Woods; Michael Kolessar; Daniel Kriz; J Renee Anderson; Hannah Olavarria; Anna W Sasaki; Michael Chang; Kenneth D Flora; Jennifer M Loftis; Marilyn Huckans
Journal:  J Neurovirol       Date:  2013-09-10       Impact factor: 2.643

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.